CID-10 e CID-11 Rápidos is a medical reference tool for healthcare professionals, providing offline access to ICD-10 and ICD-11 classification codes on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
5.0
4 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
The app removes the connectivity dependency rivals require, allowing clinicians to access diagnostic codes in environments without reliable internet access.
For Healthcare professionals including doctors, nurses, physiotherapists, and psychologists requiring rapid, offline access to medical classification codes.
What does it look like?
Key features
Unified search engine queries both ICD-10 and ICD-11 databases concurrently via code, description, or clinical synonyms.
Full ICD-10 and ICD-11 datasets stored locally on the device, requiring no internet connectivity.
Generates professionally formatted PDF documents from selected codes for administrative workflows.
How much does it cost?
The app is currently free and ad-supported, focusing on user acquisition within the medical reference market.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app exhibits a maintenance-focused development cadence, with only one release recorded in the recent window. The latest version provides only generic bug fixes, indicating a lack of new feature development or content expansion. With a cadence of approximately 9 days between updates, the developer appears to be prioritizing stability and performance over functional growth. There is no evidence of live operations or significant feature iteration.
Who built it?
Daniel Correia
7 apps tracked · Medical
User Sentiment
What do users think recently?
The recent review mood reads frustrated.
How are ratings & reviews evolving?
What users say, by theme
- Forced advertisements upon opening the app disrupt the intended use for quick information retrieval
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for CID-10 e CID-11 Rápidos
How's the Medical market?
CID-10 e CID-11 Rápidos occupies the niche of offline medical reference tools, maintaining a 5.0-star rating on iOS. The lack of Android ratings suggests the platform has yet to gain traction outside of the iOS user base.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CID-10 e CID-11 Rápidos
Where is it heading?
The medical reference market is shifting toward high-speed, frictionless interfaces that prioritize clinical efficiency. CID-10 e CID-11 Rápidos remains in a maintenance phase, and its current ad-supported model leaves it vulnerable to rivals that offer a cleaner, paid experience.
- Forced launch advertisements disrupt the intended rapid-lookup workflow, which directly contradicts the app's offline-first value proposition.
- Manual navigation requirements due to search limitations increase time-to-code, creating a high-friction experience for professional users.
The SWOT
- Offline database removes connectivity dependency
- Unified search queries ICD-10 and ICD-11 concurrently
- Implement premium ad-free tier for clinical users
- Refine search indexing to reduce manual navigation
Next best moves
Remove launch advertisements because they disrupt the primary clinical use case → increase retention
+ 1 more prioritized moveThe counter-intuitive read
The app's reliance on ads is a strategic error: in clinical reference tools…
Read the full takeSince the last report: The app's competitive positioning has shifted toward a more critical assessment of its ad-supported model, though the underlying product remains in a maintenance phase with no functional changes.
Bottom line
Transitioning to a premium, ad-free model would resolve the primary friction point for clinical users, as the current ad-supported flow directly contradicts the app's core value of speed.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store listing, source
Report last updated